Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.

Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.
复制标题

DOI:
10.3389/fimmu.2022.844271
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
Zeng D
Zeng D
中科院分区:
医学2区
文献类型:
--
作者:
Song Q;Nasri U;Zeng D

文献摘要

参考文献

相似文献

肠道移植物抗宿主病(肠道GVHD)是异基因造血干细胞移植(allo - HSCT)后导致死亡的主要原因之一。虽然全身性糖皮质激素(GCs)是一线治疗选择,但GCs的有效率在30%至50%之间。对类固醇难治性急性肠道GVHD(SR - 肠道 - aGVHD)患者的预后仍然不佳。类固醇耐药的潜在机制尚不清楚,并且除了芦可替尼之外,尚无获批用于SR - 肠道 - aGVHD的治疗方法。在这篇综述中,我们概述了目前对实验性SR - 肠道 - aGVHD发病机制的生物学认识、可应用于人类SR - 肠道 - aGVHD研究的先进技术,以及针对SR - 肠道 - aGVHD患者潜在的新型治疗选择。
Intestinal graft-versus-host disease (Gut-GVHD) is one of the major causes of mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). While systemic glucocorticoids (GCs) comprise the first-line treatment option, the response rate for GCs varies from 30% to 50%. The prognosis for patients with steroid-refractory acute Gut-GVHD (SR-Gut-aGVHD) remains dismal. The mechanisms underlying steroid resistance are unclear, and apart from ruxolitinib, there are no approved treatments for SR-Gut-aGVHD. In this review, we provide an overview of the current biological understanding of experimental SR-Gut-aGVHD pathogenesis, the advanced technology that can be applied to the human SR-Gut-aGVHD studies, and the potential novel therapeutic options for patients with SR-Gut-aGVHD.
高剂量地塞米松对免疫性血小板减少症中调节白细胞介素 22 产生和纠正 Th1 和 Th22 极化的影响
DOI: 10.1007/s10875-012-9649-4
发表时间: 2012-06-01
影响因子: 9.1
作者:
Cao, Jiang;Chen, Chong;Xu, Kai-lin
通讯作者: Xu, Kai-lin
DOI: 10.1016/j.immuni.2012.08.024
发表时间: 2012-12-14
期刊: Immunity
影响因子: 32.4
作者:
Basu R;O'Quinn DB;Silberger DJ;Schoeb TR;Fouser L;Ouyang W;Hatton RD;Weaver CT
通讯作者: Weaver CT
DOI: 10.21926/obm.transplant.1901044
发表时间: 2019
期刊: OBM transplantation
影响因子: --
作者:
Hamers AAJ;Joshi SK;Pillai AB
通讯作者: Pillai AB
DOI: 10.1002/eji.200324506
发表时间: 2004-03-01
影响因子: 5.4
作者:
Chen, X;Murakami, T;Howard, DMZ
通讯作者: Howard, DMZ
DOI: 10.1186/1476-7961-11-1
发表时间: 2013-01-25
期刊: Clinical and molecular allergy : CMA
影响因子: --
作者:
Singh AM;Dahlberg P;Burmeister K;Evans MD;Gangnon R;Roberg KA;Tisler C;Dasilva D;Pappas T;Salazar L;Lemanske RF Jr;Gern JE;Seroogy CM
通讯作者: Seroogy CM